Parallel Advisors’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $200K | Buy |
1,591
+212
| +15% | +$26.6K | ﹤0.01% | 1009 |
|
|
2025
Q1 | $153K | Sell |
1,379
-632
| -31% | -$69.9K | ﹤0.01% | 1067 |
|
|
2024
Q4 | $275K | Buy |
2,011
+172
| +9% | +$23.5K | 0.01% | 794 |
|
|
2024
Q3 | $212K | Buy |
1,839
+140
| +8% | +$16.1K | 0.01% | 897 |
|
|
2024
Q2 | $234K | Buy |
1,699
+12
| +0.7% | +$1.65K | 0.01% | 806 |
|
|
2024
Q1 | $233K | Buy |
1,687
+151
| +10% | +$20.8K | 0.01% | 806 |
|
|
2023
Q4 | $202K | Sell |
1,536
-308
| -17% | -$40.6K | 0.01% | 798 |
|
|
2023
Q3 | $207K | Buy |
1,844
+713
| +63% | +$80.2K | 0.01% | 774 |
|
|
2023
Q2 | $107K | Buy |
1,131
+88
| +8% | +$8.3K | ﹤0.01% | 1040 |
|
|
2023
Q1 | $106K | Buy |
1,043
+79
| +8% | +$8K | ﹤0.01% | 1030 |
|
|
2022
Q4 | $115K | Buy |
964
+123
| +15% | +$14.7K | 0.01% | 935 |
|
|
2022
Q3 | $89K | Buy |
841
+256
| +44% | +$27.1K | ﹤0.01% | 1012 |
|
|
2022
Q2 | $57K | Sell |
585
-54
| -8% | -$5.26K | ﹤0.01% | 1183 |
|
|
2022
Q1 | $59K | Buy |
639
+175
| +38% | +$16.2K | ﹤0.01% | 1209 |
|
|
2021
Q4 | $40K | Buy |
464
+1
| +0.2% | +$86 | ﹤0.01% | 1434 |
|
|
2021
Q3 | $44K | Buy |
463
+261
| +129% | +$24.8K | ﹤0.01% | 1316 |
|
|
2021
Q2 | $20K | Buy |
202
+27
| +15% | +$2.67K | ﹤0.01% | 1665 |
|
|
2021
Q1 | $17K | Buy |
175
+3
| +2% | +$291 | ﹤0.01% | 1655 |
|
|
2020
Q4 | $16K | Sell |
172
-1
| -0.6% | -$93 | ﹤0.01% | 1573 |
|
|
2020
Q3 | $17K | Buy |
173
+29
| +20% | +$2.85K | ﹤0.01% | 1496 |
|
|
2020
Q2 | $17K | Sell |
144
-19
| -12% | -$2.24K | ﹤0.01% | 1478 |
|
|
2020
Q1 | $14K | Buy |
163
+4
| +3% | +$344 | ﹤0.01% | 1463 |
|
|
2019
Q4 | $17K | Hold |
159
| – | – | ﹤0.01% | 1482 |
|
|
2019
Q3 | $14K | Buy |
159
+31
| +24% | +$2.73K | ﹤0.01% | 1520 |
|
|
2019
Q2 | $11K | Hold |
128
| – | – | ﹤0.01% | 1542 |
|
|
2019
Q1 | $11K | Hold |
128
| – | – | ﹤0.01% | 1487 |
|
|
2018
Q4 | $9K | Sell |
128
-6
| -4% | -$422 | ﹤0.01% | 1376 |
|
|
2018
Q3 | $16K | Hold |
134
| – | – | ﹤0.01% | 1240 |
|
|
2018
Q2 | $13K | Buy |
134
+36
| +37% | +$3.49K | ﹤0.01% | 1230 |
|
|
2018
Q1 | $8K | Hold |
98
| – | – | ﹤0.01% | 1365 |
|
|
2017
Q4 | $8K | Hold |
98
| – | – | ﹤0.01% | 1383 |
|
|
2017
Q3 | $7K | Buy |
98
+9
| +10% | +$643 | ﹤0.01% | 1435 |
|
|
2017
Q2 | $4K | Hold |
89
| – | – | ﹤0.01% | 1682 |
|
|
2017
Q1 | $5K | Buy |
89
+9
| +11% | +$506 | ﹤0.01% | 1504 |
|
|
2016
Q4 | $3K | Buy |
+80
| New | +$3K | ﹤0.01% | 1540 |
|